Precision Health Clinical Trials
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
Condition: Heart Diseases
Intervention: Other: Receive genetic risk information
Sponsor: Scripps Translational Science Institute
Recruiting
Intervention: Other: Receive genetic risk information
Sponsor: Scripps Translational Science Institute
Recruiting
For more information, visit the Study URL.
Action of the Vidaza on the Atrial Fibrillation
Conditions: Atrial Fibrillation; Acute Leukemia
Intervention: Other: Effect of Vidaza treatment
Sponsor: Hospices Civils de Lyon
Recruiting
Intervention: Other: Effect of Vidaza treatment
Sponsor: Hospices Civils de Lyon
Recruiting
For more information, visit the Study URL.
the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
Condition: Triple Negative Breast Cancer
Interventions: Drug: Vinorelbine Tartrate; Drug: Capecitabine 500 MG
Sponsor: Mario Negri Institute for Pharmacological Research
Recruiting
Interventions: Drug: Vinorelbine Tartrate; Drug: Capecitabine 500 MG
Sponsor: Mario Negri Institute for Pharmacological Research
Recruiting
For more information, visit the Study URL.
A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients
Condition: Non-small Cell Lung Cancer
Intervention: Drug: pembrolizumab
Sponsors: Sichuan University; Geneplus-Beijing Co. Ltd.
Recruiting
Intervention: Drug: pembrolizumab
Sponsors: Sichuan University; Geneplus-Beijing Co. Ltd.
Recruiting
For more information, visit the Study URL.
Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy
Conditions: Colorectal Cancer; Colorectal Cancer Metastatic; Hepatic Metastases
Intervention:
Sponsors: University Health Network, Toronto; Terry Fox Research Institute; British Columbia Cancer Agency
Recruiting
Intervention:
Sponsors: University Health Network, Toronto; Terry Fox Research Institute; British Columbia Cancer Agency
Recruiting
For more information, visit the Study URL.
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
Condition: Biliary Cirrhosis, Primary
Intervention:
Sponsor: Target PharmaSolutions, Inc.
Recruiting
Intervention:
Sponsor: Target PharmaSolutions, Inc.
Recruiting
For more information, visit the Study URL.
The Circulating Cell-free Genome Atlas Study
Conditions: Neoplasms; Cancer
Intervention:
Sponsor: GRAIL, Inc.
Recruiting
Intervention:
Sponsor: GRAIL, Inc.
Recruiting
For more information, visit the Study URL.
Pharmacogenomics of Warfarin in Hispanics and Latinos
Conditions: Thrombosis; Hemorrhage
Interventions: Procedure: Mouthwash sample; Procedure: Blood Draw
Sponsor: University of Arizona
Recruiting
Interventions: Procedure: Mouthwash sample; Procedure: Blood Draw
Sponsor: University of Arizona
Recruiting
For more information, visit the Study URL.
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Conditions: Down Syndrome; Edwards Syndrome; Patau Syndrome; Klinefelter Syndrome; Turner Syndrome; DiGeorge Syndrome; Chromosome Deletion; Aneuploidy
Intervention: Other: Blood sampling for Laboratory Developed Test (LDT) analysis
Sponsor: Progenity, Inc.
Recruiting
Intervention: Other: Blood sampling for Laboratory Developed Test (LDT) analysis
Sponsor: Progenity, Inc.
Recruiting
For more information, visit the Study URL.
Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis
Conditions: Glioblastoma; Brain Metastases
Intervention: Drug: ceritinib 750mg
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; Novartis; Wayne State University; Translational Genomics Research Institute
Recruiting
Intervention: Drug: ceritinib 750mg
Sponsors: St. Joseph's Hospital and Medical Center, Phoenix; Novartis; Wayne State University; Translational Genomics Research Institute
Recruiting
For more information, visit the Study URL.


